EA
AKAO

Emerald Acquisition’s Achaogen Inc AKAO Stock Holding History

Emerald Acquisition’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,147
Closed -$27K – 3100
2016
Q2 		$27K Buy
+7,147
New +$24.9K ﹤0.01% 2954

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Emerald Acquisition's AKAO Position: Q3 2016 in Review

Emerald Acquisition sold out of Achaogen Inc (AKAO) in Q3 2016, closing a stake of 7,147 shares — an estimated $27K sold.

Emerald Acquisition first reported a position in AKAO in Q2 2016 and held it in 1 quarter. The position peaked at $27K in Q2 2016. 37 funds tracked by Wall St. Rank hold AKAO as of Q3 2016.

  • Emerald Acquisition reported no remaining Achaogen Inc position as of Q3 2016 after selling out during the quarter.
  • Emerald Acquisition sold 7,147 Achaogen Inc shares in Q3 2016, an estimated $27K.
  • Emerald Acquisition first reported a position in Achaogen Inc in Q2 2016 and held it in 1 quarter.
  • Emerald Acquisition's Achaogen Inc position peaked at $27K in Q2 2016.
  • 37 funds tracked by Wall St. Rank held Achaogen Inc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.